Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3

4(66.7%)

Phase 1

1(16.7%)

Phase 2

1(16.7%)

6Total

Phase 3(4)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07357935Phase 1Not Yet Recruiting

Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia

Role: lead

NCT07152600Phase 3Not Yet Recruiting

Adaptive RCT of Corticosteroids for Severe Adenovirus Pneumonia in Adults

Role: lead

NCT07351500Phase 3Not Yet Recruiting

Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in Adults

Role: lead

NCT07352865Phase 3Not Yet Recruiting

Adaptive RCT of Corticosteroids for Severe Chlamydia Psittaci Pneumonia in Adults

Role: lead

NCT07152613Phase 3Not Yet Recruiting

Corticosteroids for PJP in Non-HIV Immunocompromised Adults

Role: lead

NCT07152587Phase 2Not Yet Recruiting

Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal)

Role: lead

NCT05627505Unknown

Diagnostic and Prognostic Value of Lung Microbiota in Early Lung Infection After Lung Transplantation

Role: lead

All 7 trials loaded